LLY

801.28

-3.03%↓

UNH

561.73

+2.26%↑

JNJ

149.63

+0.22%↑

NVO

111.12

+0.31%↑

ABBV

176.55

+0.19%↑

LLY

801.28

-3.03%↓

UNH

561.73

+2.26%↑

JNJ

149.63

+0.22%↑

NVO

111.12

+0.31%↑

ABBV

176.55

+0.19%↑

LLY

801.28

-3.03%↓

UNH

561.73

+2.26%↑

JNJ

149.63

+0.22%↑

NVO

111.12

+0.31%↑

ABBV

176.55

+0.19%↑

LLY

801.28

-3.03%↓

UNH

561.73

+2.26%↑

JNJ

149.63

+0.22%↑

NVO

111.12

+0.31%↑

ABBV

176.55

+0.19%↑

LLY

801.28

-3.03%↓

UNH

561.73

+2.26%↑

JNJ

149.63

+0.22%↑

NVO

111.12

+0.31%↑

ABBV

176.55

+0.19%↑

Search

Artivion Inc

Cerrado

Sector Salud

28.98 -2.13

Resumen

Variación precio

24h

Actual

Mínimo

28.36

Máximo

29.4

Métricas clave

By Trading Economics

Ingresos

-2.3M

Ventas

2.1M

96M

BPA

-0.05

Margen de beneficio

-2.389

Empleados

1,500

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+11.83 upside

Dividendos

By Dow Jones

Próximas Ganancias

13 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

12M

892M

Apertura anterior

31.11

Cierre anterior

28.98

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

189 / 392 Clasificación en Healthcare

Artivion Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

9 dic 2024, 22:52 UTC

Adquisiciones, fusiones, absorciones

Perpetual, KKR in Talks About Deal as Tax Assessment Disappoints

9 dic 2024, 21:38 UTC

Principales Noticias
Ganancias

Oracle Posts Higher 2Q Revenue, Profit; Shares Fall After Earnings Miss Estimates

9 dic 2024, 23:05 UTC

Ganancias

Oracle Earnings, Revenue Fall Short of High Hopes -- Barrons.com

9 dic 2024, 22:58 UTC

Charlas de Mercado

S&P Economics Expects Canada Rate Cut Wednesday -- Market Talk

9 dic 2024, 22:50 UTC

Ganancias

Bitfarms: Announces Restatement of Previously Issued Fincl Statements

9 dic 2024, 21:56 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Asset Management has Delivered Growth in AUM So Far in 2Q

9 dic 2024, 21:55 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Corporate Trust, Wealth Management Continuing Strong Performance Trajectory in 2Q

9 dic 2024, 21:54 UTC

Adquisiciones, fusiones, absorciones

Perpetual 1Q Wealth Management Funds Under Advice Up by 3% to A$20.4 Billion

9 dic 2024, 21:54 UTC

Adquisiciones, fusiones, absorciones

Perpetual 1Q Corporate Trust Funds Under Administration Up by 1% to A$1.2 Trillion

9 dic 2024, 21:53 UTC

Adquisiciones, fusiones, absorciones

Perpetual 1Q Asset Management's AUM Up By 3% to A$222.3 Billion

9 dic 2024, 21:53 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Discussing With KKR Potential Impact on Deal

9 dic 2024, 21:52 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Would Need to Withhold Sufficient Funds to Cover Liability During Dispute Process

9 dic 2024, 21:51 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Considers if Has Strong Grounds to Dispute

9 dic 2024, 21:51 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Continues to be of View That Provisions Should Not Apply

9 dic 2024, 21:50 UTC

Adquisiciones, fusiones, absorciones

Perpetual: 'Extremely Disappointed,' Disagrees With Commissioner's Views

9 dic 2024, 21:50 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Cash Proceeds to Shareholders Previously Estimated at A$8.38-A$9.82/Share

9 dic 2024, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 dic 2024, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

9 dic 2024, 21:49 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Estimated Cash Proceeds to Shareholders Would Reduce to A$5.74-A$6.42/Share

9 dic 2024, 21:49 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Range of Taxes, Duties Previously Estimated at A$106 Million-A$227 Million

9 dic 2024, 21:49 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Range of Taxes, Duties Now Estimated to be Between A$493 Million-A$529 Million

9 dic 2024, 21:48 UTC

Adquisiciones, fusiones, absorciones

Perpetual: If Part IVA Applies, Tax Liability Estimated to be A$488 Million Without Additional Penalties, Interest

9 dic 2024, 21:47 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Tax Commissioner Declined to Provide Binding Ruling That Part IVA Won't Apply

9 dic 2024, 21:46 UTC

Adquisiciones, fusiones, absorciones

Perpetual: That Would Mean Proceeds Are Taxed at Applicable Rate for Each Shareholder

9 dic 2024, 21:46 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Entire Cash Proceeds on Disposal of TopCo Could be Deemed Assessable Unfranked Dividend

9 dic 2024, 21:45 UTC

Adquisiciones, fusiones, absorciones

Perpetual: Australian Taxation Office Says Section 45B of the Income Tax Assessment Act Would Apply to KKR Scheme

9 dic 2024, 21:27 UTC

Ganancias

Oracle Earnings, Revenue Fall Short of High Hopes -- Barrons.com

9 dic 2024, 21:21 UTC

Principales Noticias
Ganancias

Oracle Stock Falls On Earnings, Sales Miss. Tech Giant Touts Strong AI Demand. -- IBD

9 dic 2024, 21:15 UTC

Ganancias

C3.ai Reports Smaller-Than-Expected Loss. The Stock Jumps. -- Barrons.com

9 dic 2024, 21:15 UTC

Principales Noticias

China Probe Weighs on Nvidia Stock; S&P 500 Falls -- WSJ

Comparación entre iguales

Cambio de precio

Artivion Inc Esperado

Precio Objetivo

By TipRanks

11.83% repunte

Estimación a 12 meses

Media 33.17 USD  11.83%

Máximo 35 USD

Mínimo 32 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Artivion Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

189 / 392 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Artivion Inc

CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.